GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **926 - 950** of **4050** in total

« First

‹ Prev

…

34

35

36

37

38

39

40

41

42

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G76615YG	7007
IgM	Patient 3	4	mild	G76615YG	7267
IgA	Patient 4	12	mild	G76615YG	478
IgG	Patient 4	12	mild	G76615YG	88
IgM	Patient 4	12	mild	G76615YG	339
IgA	Patient 1	10	moderate	G76355TG	375
IgA	Patient 1	22	moderate	G76355TG	392
IgA	Patient 1	6	moderate	G76355TG	375
IgG	Patient 1	10	moderate	G76355TG	22
IgG	Patient 1	22	moderate	G76355TG	25
IgM	Patient 1	10	moderate	G76355TG	46
IgM	Patient 1	22	moderate	G76355TG	58
IgA	Patient 2	15	mild	G76355TG	1163
IgA	Patient 2	24	mild	G76355TG	1279
IgG	Patient 2	15	mild	G76355TG	207
IgG	Patient 2	24	mild	G76355TG	210
IgM	Patient 2	15	mild	G76355TG	2231
IgM	Patient 2	24	mild	G76355TG	2417
IgG	Patient 1	6	moderate	G76355TG	28
IgM	Patient 1	6	moderate	G76355TG	57
IgA	Patient 2	3	mild	G76355TG	538
IgG	Patient 2	3	mild	G76355TG	43
IgM	Patient 2	3	mild	G76355TG	112
IgA	Patient 3	-180	mild	G76355TG	278
IgA	Patient 3	11	mild	G76355TG	398